The Year in Coagulation and Transfusion: Selected Highlights from 2022

J Cardiothorac Vasc Anesth. 2023 Dec;37(12):2435-2449. doi: 10.1053/j.jvca.2023.08.132. Epub 2023 Aug 17.

Abstract

This is an annual review to cover highlights in transfusion and coagulation in patients undergoing cardiovascular surgery. The goal of this article is to provide readers with a focused summary of the most important transfusion and coagulation topics published in 2022. This includes a discussion covering the management of anemia and red blood cell transfusion, the management of factor Xa inhibitors, updates in coagulation testing, updates in the use of factor concentrates, advances in platelet therapy, advances in anticoagulation management of patients on extracorporeal membrane oxygenation and other forms of mechanical circulatory support, and advances in the diagnosis and management of heparin-induced thrombocytopenia.

Keywords: anemia; cardiopulmonary bypass; coagulation; factor concentrates; transfusion; viscoelastic testing.

MeSH terms

  • Anticoagulants / adverse effects
  • Blood Coagulation Tests
  • Blood Coagulation*
  • Blood Platelets
  • Blood Transfusion
  • Heparin
  • Humans
  • Thrombocytopenia* / chemically induced
  • Thrombocytopenia* / diagnosis
  • Thrombocytopenia* / therapy

Substances

  • Heparin
  • Anticoagulants